PowerHive, Vikram Solar’s energy storage subsidiary, has launched the VION lithium battery range for homes, e-rickshaws, and distributed energy projects, marking the company’s entry into electric ...

Concentra demonstrates dominant market positioning, leveraging scale and integration with major employers to achieve consistent double-digit revenue and EBITDA growth. Preliminary 2025 results show 13 ...

New Delhi: Vikram Solar on Wednesday announced the appointment of Arun Mittal as Chief Executive Officer of VSL Powerhive, its wholly owned subsidiary.In a statement, Gyanesh Chaudhary, Chairman & ...

Good morning, and thank you for joining us today for Concentra Group Holdings Parent, Inc. Earnings conference call to discuss the third quarter 2025 results. Speaking today are the company's Chief ...

DALLAS, Nov. 6, 2025 /PRNewswire/ -- Concentric's PowerHIVE™, an autonomous forklift battery management system, has surpassed 250,000 battery swaps, marking the system's rapid adoption and impact in ...

Elevation Oncology , Inc. (NASDAQ:ELEV), whose shares have declined over 86% in the past year according to InvestingPro data, announced Wednesday the completion of its merger with Concentra ...

CAR-T therapy developer CARGO Therapeutics has found a way forward after abandoning its clinical programmes and slashing staff to the bone earlier this year: a merger with Concentra Biosciences.

As biotech companies struggle, laying off staff and cutting drug research, a well-funded firm in Southern California watches closely for the right time to strike. This year, it’s struck again and ...

Days after picking up IGM Biosciences, serial biotech acquirer Concentra Biosciences has secured another company in the form of cash-strapped Cargo Therapeutics. The deal will see Tang Capital ...

Powerhive and Telcoin are democratizing mobility financing through blockchain, regulated Digital Cash, and mobile-first payments to empower emerging markets. Powerhive, a pioneer in decentralized ...

With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. Tang Capital Partners’ Concentra inked a definitive deal to acquire Kronos’ ...

(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...